Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hu14.18K322A in High-Risk Neuroblastoma
NCT01857934Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jul 2013
- Primary completion
- Oct 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of daretabart in neuroblastoma, sponsored by St. Jude Children's Research Hospital. Started Jul 2013; status: completed.
02
Drugs
daretabart
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT01857934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857934.